News
People with the rare growth hormone disorder acromegaly have a significantly higher risk of developing various types of ...
People with the rare growth hormone disorder acromegaly have a significantly higher risk of developing various types of cancer, often at ages younger than typically seen in the general population, ...
Most adults with acromegaly reduced IGF-1 levels and improved acromegaly symptoms with once-monthly subcutaneous octreotide ...
1d
Clinical Trials Arena on MSNCrinetics reveals new data from acromegaly therapy programmeThe Palsonify-treated subjects maintained control, with stable growth hormone levels, symptom scores, and pituitary tumour ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results